PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1209786
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1209786
Transplantation Market Forecasts to 2028 - Global Analysis By Product, Application, End User and By Geography
According to Stratistics MRC, the Global Transplantation Market is accounted for $13.8 billion in 2022 and is expected to reach $26.4 billion by 2028 growing at a CAGR of 11.4% during the forecast period. Transplantation is a surgical procedure of implanting an organ or tissue from one body to another body. It is usually done when there is an organ failure. Organ failure generally occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukaemia, sepsis and other acute diseases. Transplantation was done to organs like heart, kidneys, liver, lungs, pancreas, intestine, thymus and uterus. Increase in chronic diseases such as kidney failure and lupus needs immediate change of organs which led to rise in transplantation.
According to the preliminary data from the Organ Procurement and Transplantation Network (OPTN), 42,000 organ transplants were performed in U.S with an increase of 5.9% and 1,22,915 patients are waiting to receive organs for transplant.
Market Dynamics:
Driver:
Increasing demand of 3D bioprinting
The continuous shortage of organ donors and the increasing number of patients on the waiting list for organ transplants have increased the demand for 3D bioprinting. These techniques are used to create customized prosthetics, fabricate tissue, and to support transplantation through synthetic models. The introduction of 3D bioprinting techniques has led to the growth of the transplantation market by driving the number of organ transplant procedures globally.
Restraint:
High cost for transplantation
Organ transplantation accumulates high cost due to its large process because every transplant organ must go through a series of evaluation, matching, screening and waiting procedures before it can be used in the transplant surgery. It is often difficult for patients to secure organs and transplant surgeries. The costs include the patient's hospitalization as they stay before transplant also. Acquisition of organ donor for lesser prices is the most difficult aspect. This reason hampers the market growth.
Opportunity:
Advancement in transplantation technology
Advancement in transplantation technology and the launch of new products by manufacturers has raised the number of transplant procedures including kidney, liver, heart, lungs and tissues. This increased the number of transplant centers and healthcare centers. Well-developed healthcare infrastructure and availability of expert surgeons & advanced products with better technology has propelled the growth of the market.
Threat:
Extensive wait time
Organ transplantation takes extensive wait time due to the fewer organ donations. There is an increased need for these procedures to care for the critically patient population effectively. Even the donor is ready to donate the organ; the organ should match all the requisites and should be fully fledgeble to be transplanted. To get a perfect donor, it will almost take few months and can also be extended for too many years. This can sometimes even cause death of the patient and thus it hinders the growth of the market.
COVID-19 Impact
The covid pandemic did not hit the healthcare industry into disarray but caused a drop in organ transplant surgery enrolment worldwide. The decrease in the number of transplantation and organ donation procedures is mainly because of factors such as unavailability of resources, engaged surgeons, lockdown and travel restrictions. Patients with positive reports for COVID-19 were refrained from donating organs due to the possibility of infection. The immunosuppressant drug interactions with COVID-19 therapy agents, had led to a significant number of organ failures from graft donors which became the major concern.
The tissue products segment is expected to be the largest during the forecast period
The tissue products segment is estimated to have a lucrative growth, due to its new product development. Major products used for tissue or organ transplantation are tissue products, immune suppressants and preservation solutions. It has raised the orthopedic procedures for tissue healing, normal functioning restoration and pain minimization. The increasing number of transplantation procedures such as that of cochlear, heart valves, bone marrow and orthopedic soft tissues and the rising geriatric population across the globe is attributed to the growth of the segment.
The immunosuppressive drugs segment is expected to have the highest CAGR during the forecast period
The immunosuppressive drugs segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the benefits this drug offers such as lowering the body ability to reject a transplanted organ. These drugs are highly used for auto immune disorders, such as alopecia areata, multiple sclerosis and arthritis, combined with the rising incidence of organ failures, especially the kidneys, lungs, liver, and heart.
Region with highest share:
North America is projected to hold the largest market share during the forecast period owing to their continuous development of innovative transplantation products for treatment. This region has well-developed healthcare system. The population here are increasing expenditure on personal health drastically. Strong presence of various large-scale biotechnology and medical device companies and presence of supportive government policies is expected to drive revenue growth of this region.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the increase in chronic diseases and road accidents. High prevalence of various chronic diseases and increasing incidence of road accidents are causing permanent damage to the organs resulting in replacement of damaged organs with healthy organs in order to save patient's life. Continuous advancements in transplantation technology by major players in this region are registering the steady growth in the market.
Key players in the market
Some of the key players profiled in the Transplantation Market include Novartis AG, 21st Century Medicine, Stryker Corporation, TransMedics, Zimmer Biomet, Astellas Pharma Inc, Medtronic, AbbVie Inc, Biolife Solutions, Teva Pharmaceutical, Veloxis Pharmaceuticals Inc, Abbott, Becton, Dickinson and Company (BD), BioMerieux SA, Bio-Rad Laboratories Inc, CareDx Inc, F. Hoffmann-La Roche Ltd, Hologic Inc, Illumina Inc, QIAGEN and Arthrex Inc.
Key Developments:
In March 2022, Zimmer Biomet entered into a multiyear agreement with Bio composites to exclusively distribute Genex Bone Graft Substitute with its new mixing system and delivery options in the U.S.
In January 2022, Novartis AG collaborated with Alnylam intending to explore targeted therapy to restore liver function. Alnylam's Sirna technology is intended to promote the regrowth of functional liver cells and is an alternative for liver failure patients.
Products Covered:
- Preservation Solutions
- Tissue Products
- Immunosuppressive Drugs
- Other Products
Applications Covered:
- Tissue Transplant
- Organ Transplant
- Other Applications
End Users Covered:
- Transplantation Centers
- Hospitals
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Transplantation Market, By Product
- 5.1 Introduction
- 5.2 Preservation Solutions
- 5.3 Tissue Products
- 5.4 Immunosuppressive Drugs
- 5.5 Other Products
6 Global Transplantation Market, By Application
- 6.1 Introduction
- 6.2 Tissue Transplant
- 6.3 Organ Transplant
- 6.4 Other Applications
7 Global Transplantation Market, By End User
- 7.1 Introduction
- 7.2 Transplantation Centers
- 7.3 Hospitals
- 7.4 Other End Users
8 Global Transplantation Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Novartis AG
- 10.2 21 st Century Medicine
- 10.3 Stryker Corporation
- 10.4 TransMedics
- 10.5 Zimmer Biomet
- 10.6 Astellas Pharma Inc
- 10.7 Medtronic
- 10.8 AbbVie Inc
- 10.9 Biolife Solutions
- 10.10 Teva Pharmaceutical
- 10.11 Veloxis Pharmaceuticals Inc
- 10.12 Abbott
- 10.13 Becton, Dickinson and Company (BD)
- 10.14 BioMerieux SA
- 10.15 Bio-Rad Laboratories Inc
- 10.16 CareDx Inc
- 10.17 F. Hoffmann-La Roche Ltd
- 10.18 Hologic Inc
- 10.19 Illumina Inc
- 10.20 QIAGEN
- 10.21 Arthrex Inc
List of Tables
- Table 1 Global Transplantation Market Outlook, By Region (2020-2028) ($MN)
- Table 2 Global Transplantation Market Outlook, By Product (2020-2028) ($MN)
- Table 3 Global Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
- Table 4 Global Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
- Table 5 Global Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
- Table 6 Global Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
- Table 7 Global Transplantation Market Outlook, By Application (2020-2028) ($MN)
- Table 8 Global Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
- Table 9 Global Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
- Table 10 Global Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
- Table 11 Global Transplantation Market Outlook, By End User (2020-2028) ($MN)
- Table 12 Global Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
- Table 13 Global Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 14 Global Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 15 North America Transplantation Market Outlook, By Country (2020-2028) ($MN)
- Table 16 North America Transplantation Market Outlook, By Product (2020-2028) ($MN)
- Table 17 North America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
- Table 18 North America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
- Table 19 North America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
- Table 20 North America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
- Table 21 North America Transplantation Market Outlook, By Application (2020-2028) ($MN)
- Table 22 North America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
- Table 23 North America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
- Table 24 North America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
- Table 25 North America Transplantation Market Outlook, By End User (2020-2028) ($MN)
- Table 26 North America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
- Table 27 North America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 28 North America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 29 Europe Transplantation Market Outlook, By Country (2020-2028) ($MN)
- Table 30 Europe Transplantation Market Outlook, By Product (2020-2028) ($MN)
- Table 31 Europe Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
- Table 32 Europe Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
- Table 33 Europe Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
- Table 34 Europe Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
- Table 35 Europe Transplantation Market Outlook, By Application (2020-2028) ($MN)
- Table 36 Europe Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
- Table 37 Europe Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
- Table 38 Europe Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
- Table 39 Europe Transplantation Market Outlook, By End User (2020-2028) ($MN)
- Table 40 Europe Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
- Table 41 Europe Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 42 Europe Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 43 Asia Pacific Transplantation Market Outlook, By Country (2020-2028) ($MN)
- Table 44 Asia Pacific Transplantation Market Outlook, By Product (2020-2028) ($MN)
- Table 45 Asia Pacific Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
- Table 46 Asia Pacific Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
- Table 47 Asia Pacific Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
- Table 48 Asia Pacific Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
- Table 49 Asia Pacific Transplantation Market Outlook, By Application (2020-2028) ($MN)
- Table 50 Asia Pacific Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
- Table 51 Asia Pacific Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
- Table 52 Asia Pacific Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
- Table 53 Asia Pacific Transplantation Market Outlook, By End User (2020-2028) ($MN)
- Table 54 Asia Pacific Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
- Table 55 Asia Pacific Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 56 Asia Pacific Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 57 South America Transplantation Market Outlook, By Country (2020-2028) ($MN)
- Table 58 South America Transplantation Market Outlook, By Product (2020-2028) ($MN)
- Table 59 South America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
- Table 60 South America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
- Table 61 South America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
- Table 62 South America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
- Table 63 South America Transplantation Market Outlook, By Application (2020-2028) ($MN)
- Table 64 South America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
- Table 65 South America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
- Table 66 South America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
- Table 67 South America Transplantation Market Outlook, By End User (2020-2028) ($MN)
- Table 68 South America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
- Table 69 South America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 70 South America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
- Table 71 Middle East & Africa Transplantation Market Outlook, By Country (2020-2028) ($MN)
- Table 72 Middle East & Africa Transplantation Market Outlook, By Product (2020-2028) ($MN)
- Table 73 Middle East & Africa Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
- Table 74 Middle East & Africa Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
- Table 75 Middle East & Africa Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
- Table 76 Middle East & Africa Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
- Table 77 Middle East & Africa Transplantation Market Outlook, By Application (2020-2028) ($MN)
- Table 78 Middle East & Africa Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
- Table 79 Middle East & Africa Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
- Table 80 Middle East & Africa Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
- Table 81 Middle East & Africa Transplantation Market Outlook, By End User (2020-2028) ($MN)
- Table 82 Middle East & Africa Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
- Table 83 Middle East & Africa Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
- Table 84 Middle East & Africa Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
